APOE in the Predisposition to, Protection From, and Prevention of Alzheimer's Disease

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Banner Health
Study ID
NCT04994847
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 90 Years
Healthy Volunteers
Accepted

Interventions

  • Amyloid and Tau PET — DRUG
    NAV4694 and MK6240 PET scans completed every two years

Study Details

The purpose of this study is to track changes in the brain related to Alzheimer's disease. The results from this study will be used to develop new approaches to prevent or delay the onset of memory and thinking problems associated with Alzheimer's.

Key Dates

Start date
May 1, 2021
Status verified
Jul 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: APOE Unimpaired Observational Trial
    300 participants who are cognitively unimpaired; Yearly procedures: blood draw Every Two Year Procedures: cognitive and clinical assessments, CSF collection, MRI, and Tau and Amyloid PET scans

Primary Outcome Measure

Amyloid PET Scan [ Time Frame: 5 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Banner Alzheimer's InstitutePhoenixArizona85006-

Find similar trials in Phoenix, AZ

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Banner Alzheimer's Institute· Phoenix, AZ

Related Studies